Stock Analysis: Cvs Health Corp (CVS)

Stock Analysis for Cvs Health Corp (CVS)

The Interpreter
Hey Friend, I'm analysing CVS HEALTH CORP (CVS), and it is between the Support of $ 67.49 (PivotS2) and the Resistance of $ 69.87 (38.2% of Fibonacci). The stock is also approaching the line of PivotS2 at $ 67.49, and if it goes below this line it could reach the next Support of 0% of Fibonacci at $ 66.71.

Cvs Health Corp (CVS)

$ 68.50 -1.6%

Last Close 23-Apr-24

Trade CVS Now

Supports

Next Support: $ 67.49

Pivot S2: $ 67.49
Fibonacci 0%: $ 66.71
Triangle Level (2): $ 62.06

Resistances

Next Resistance: $ 69.87

Pivot S1: $ 71.03
Fibonacci 38.2%: $ 69.87
Triangle Level (0): $ 72.65

Supports and Resistances

Click to Enlarge

Candlesticks, "48-hour" Trade Signals +

Date	Price $	Result %	Candle Name	Side
001 09 Feb 2024	Buy Price: 76.32	Profit: Close Day1 ($ 77.29)	Engulfing	Buy
002 01 Feb 2024	Sell Price: 73.92	Profit: Close Day1 ($ 73.09)	Engulfing	Sell
003 16 Oct 2023	Sell Price: 71.49	Profit: Open Day1 ($ 71.18)	Dark Cloud Cover	Sell
004 11 Aug 2023	Buy Price: 74.87	Loss: Close Day2 ($ 73.33)	Engulfing	Buy
005 10 Aug 2023	Sell Price: 73.80	Profit: Open Day1 ($ 73.76)	Engulfing	Sell
006 10 Aug 2023	Sell Price: 73.96	Profit: Open Day1 ($ 73.76)	Dark Cloud Cover	Sell
007 12 Jun 2023	Sell Price: 71.50	Profit: Open Day2 ($ 68.27)	Abandoned Baby	Sell
008One Year Average	Both Sides Result for 7 Signals	Profit: $ 4.03 ($ 0.58 / Signal) +5.5% Gross in 1 Year	All of Them	Buy + Sell

Trading Rules for Candlesticks Patterns.

Buy or Sell on the same day of the signal, during the after-hours trading session.
Watch the Opening and Closing of the next 2 days (4 in total).
Immediately exit the Trade when one of them (Open or Close, Day 1 or 2) gives you a profit.
The table above will show the first Profit opportunity, but not in real-time. Therefore, you must watch the market in real-time with your broker.

Remember: The returns an asset made in the past don't mean that future returns will be the same.

Backtest Lab, "Buy The Dip" Trade Signals +

Find The Lastest Buy Signals for CVS Below.

Please Subscribe to See
The Latest Trade Signals

Moving Averages +

Bought Moving Averages

Sold Moving Averages

Simple Moving Averages (SMA) Period	Value $	Signal	Exponential Moving Averages (EMA) Period	Value $	Signal
2	69.07	SELL	2	68.87	SELL
3	69.29	SELL	3	69.02	SELL
5	69.17	SELL	5	69.21	SELL
8	69.06	SELL	8	69.66	SELL
13	70.44	SELL	13	70.63	SELL
21	73.10	SELL	21	71.90	SELL
34	74.42	SELL	34	73.10	SELL
55	74.90	SELL	55	73.88	SELL
90	75.59	SELL	90	74.07	SELL
200	72.73	SELL	200	74.60	SELL

Company Info +

Name & IPO

Cvs Health Corp
IPO: 1952-10-01

Stock Ticker & Exchange

Ticker: CVSIndices: S&P 500,
Exchange: New York Stock Exchange, Inc. (US - USD)

Contact

Website: https://cvshealth.com/
Phone:

Stock Type

Common Stock

SIC Office

Trade & Services ()

Industry

Retail-drug Stores And Proprietary Stores

EIN

Fiscal Year End

State of Inc.

Balance Sheets +

in USD millions (if not decimal) - Dictionary

	Year	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
1	Assets +	230,715	222,449	196,456	95,131	94,462	93,657	74,252	71,526	66,221	64,852	62,169	61,641	60,960	1,056	530
2	Real Estate Investment Property +	0	0	0	0	0	0	0	0	0	0	1,247	1,076	0	0	0
3	Real Estate Investment Property +	0	0	0	0	0	0	0	0	0	0	1,247	1,076	0	0	0
4	Cash and Cash Equivalents +	7,854	5,683	4,059	1,696	3,371	2,459	2,481	4,089	1,375	1,413	1,427	1,086	1,352	1,056	530
5	Property +	12,606	12,044	11,349	10,292	10,175	9,855	8,843	8,615	8,632	8,467	8,322	7,923	8,125	0	0
6	Property +	31,306	28,934	26,869	24,290	22,802	21,036	18,786	17,408	16,306	15,400	14,283	12,944	0	0	0
7	Intangible Assets +	31,142	33,121	36,524	13,630	13,511	13,878	9,774	9,529	9,753	9,869	9,784	10,127	10,446	0	0
8	Finite-Lived Intangible Assets +	-10,481	-9,038	-7,214	-6,299	-5,495	-4,709	-4,025	-3,509	23,208	23,775	23,421	0	0	0	0
9	Liabilities and Equity +	230,715	222,449	196,456	95,131	94,462	93,657	74,252	71,526	66,221	64,543	62,169	61,641	60,960	31,322	0
10	Liabilities +	161,014	158,279	137,913	57,436	28,124	23,169	19,712	15,425	14,840	12,706	11,370	12,615	16,534	0	0
11	Debt and Lease Obligation +	0	0	720	1,276	1,874	0	685	0	690	750	300	315	3,044	0	0
12	Temporary Equity +	0	0	0	0	0	39	0	0	0	0	0	0	0	0	0
13	Redeemable Noncontrolling Interest +	0	0	0	0	0	39	0	0	0	0	0	0	0	0	0
14	Stockholders' Equity +	69,701	64,170	58,543	37,695	36,834	37,203	37,963	37,938	37,653	38,013	37,700	35,768	34,574	31,322	0
15	Stockholders' Equity Attributable to Parent +	69,389	63,864	58,225	37,691	36,830	37,196	37,958	37,938	37,653	16	37,700	35,768	34,574	31,322	0
16	Stockholders' Equity +	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0	0
17	Preferred Stock +	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0	0	0
18	Common Stock +	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0	0
19	Partners' Capital +	49,640	45,108	40,911	43,556	38,983	35,506	31,849	28,493	24,998	22,090	19,303	16,355	13,098	0	0
20	Partners' Capital +	49,640	45,108	40,911	43,556	38,983	35,506	31,849	28,493	24,998	22,090	19,303	16,355	13,098	0	0
21	Limited Liability Company (LLC) Members' Equity +	51,054	46,127	41,013	43,391	38,678	35,148	31,632	28,344	24,817	21,918	19,160	16,220	12,955	0	0
22	Limited Liability Company (LLC) Members' Equity +	51,054	46,127	41,013	43,391	38,678	35,148	31,632	28,344	24,817	21,918	19,160	16,220	12,955	0	0
23	Current Assets +	56,369	50,302	45,243	31,229	31,042	30,378	25,983	25,325	20,161	18,594	17,706	17,537	16,526	0	0
24	Cash +	3,000	2,373	2,528	125	87	88	34	88	5	5	4	5	0	0	0
25	Current Receivables +	21,742	19,617	17,631	13,181	12,164	11,888	9,687	8,729	6,479	6,047	4,925	5,457	5,384	0	0
26	Inventory +	18,496	17,516	16,450	15,296	14,760	14,001	11,930	11,045	11,032	10,046	10,695	10,343	9,153	0	0
27	Current Contract with Customer +	7,101	6,717	6,896	7,895	0	0	0	0	0	0	0	0	0	0	0
28	Long-Term Assets +	104,905	105,209	83,724	39,868	39,734	39,546	29,652	28,057	27,675	27,613	26,357	26,054	25,863	0	0
29	Long-term Investments and Receivables +	20,812	17,314	15,732	112	0	0	51	0	0	0	0	0	0	0	0
30	Long-Term Restricted Cash and Investments +	276	271	230	190	0	0	0	0	0	0	0	0	0	0	0
31	Current Liabilities +	62,017	53,303	44,009	30,648	26,250	23,169	19,027	15,425	14,150	11,956	11,070	12,300	13,490	0	0
32	Long-Term Other Undisclosed Liabilities	11,888	11,895	0	0	0	0	0	0	0	0	0	0	0	0	0
33	Long-Term Liabilities +	98,997	104,976	82,170	26,760	27,164	27,809	13,226	14,262	10,634	10,653	9,710	9,858	9,194	0	0
34	Increase (Decrease) in Stockholders' Equity [Roll Forward] +	-28,178	-28,235	-28,228	-37,796	-33,452	-28,886	-24,078	-20,169	-16,270	-11,953	-9,030	-7,610	-5,812	0	0
35	Treasury Stock Transactions +	-28,178	-28,235	-28,228	-37,796	-33,452	-28,886	-24,078	-20,169	-16,270	-11,953	-9,030	-7,610	-5,812	0	0
36	Treasury Stock +	-28,178	-28,235	-28,228	-37,796	-33,452	-28,886	-24,078	-20,169	-16,270	-11,953	-9,030	-7,610	-5,812	0	0
37	Current Other Assets +	5,277	5,113	4,581	945	660	722	866	472	577	580	144	140	202	0	0
38	Total Current Assets +	56,369	50,302	45,243	31,229	31,042	30,378	25,983	25,325	20,161	18,594	17,706	17,537	16,526	0	0
39	Operating Lease +	20,729	20,860	0	0	0	0	0	0	0	0	0	0	0	0	0
40	Goodwill +	79,552	79,749	78,678	38,451	38,249	38,106	28,142	26,542	26,395	26,458	25,669	25,680	25,494	0	0
41	Long-Term Other Assets +	4,624	4,600	5,046	1,417	1,485	1,440	1,510	1,515	1,280	1,155	688	374	369	0	0
42	Total Assets +	230,715	222,449	196,456	95,131	94,462	93,657	74,252	71,526	66,221	64,852	62,169	61,641	60,960	0	0
43	Total Liabilities +	161,014	158,279	137,913	57,436	0	0	0	0	0	0	0	0	0	0	0
44	Stockholders' Equity Attributable to Noncontrolling Interest +	312	306	318	4	4	7	5	0	0	0	0	0	0	0	0
45	Total Stockholders' Equity +	69,701	64,170	58,543	37,695	36,834	37,203	37,963	37,938	37,653	38,013	37,700	35,768	34,574	0	0
46	Total Liabilities and Equity +	230,715	222,449	196,456	95,131	94,462	93,657	74,252	71,526	66,221	64,543	62,169	61,641	60,960	0	0

Income Statement +

in USD millions (if not decimal) - Dictionary

	Year	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
1	Premiums Earned +	69,419	63,172	8,184	3,558	0	0	0	0	0	0	0	0	0	0
2	Total Revenues +	268,706	256,776	194,579	184,786	177,526	153,290	139,367	126,761	123,120	107,080	95,778	98,215	87,472	76,330
3	Total Cost of Goods and Services Sold +	-163,981	-158,719	-156,447	-153,448	-146,533	0	0	0	0	0	0	0	0	0
4	Policyholder Benefits and Claims Incurred +	55,679	52,529	6,594	2,810	2,179	0	0	0	0	0	0	0	0	0
5	Total Cost of Revenue +	0	0	0	-156,220	-148,669	-126,762	-114,000	-102,978	-100,632	-86,518	-75,559	-77,857	-69,182	-60,222
6	Total Gross Profit +	0	0	0	28,545	28,857	26,528	25,367	23,783	22,488	20,562	20,219	20,358	18,290	16,108
7	Total Depreciation +	0	0	0	2,480	2,475	2,092	1,931	1,870	1,753	1,568	1,469	1,389	1,274	1,095
8	Defined Benefit Plan +	0	0	0	187	0	0	0	0	0	0	0	0	0	0
9	Gain (Loss) Related to Litigation Settlement +	0	0	0	0	0	0	0	-72	0	0	0	0	0	0
10	Business Combination +	332	480	492	65	0	0	0	0	0	0	0	0	0	0
11	Other Cost and Expense +	0	0	21,860	18,874	18,448	0	0	0	0	0	0	0	0	0
12	Accounts Receivable +	0	111	256	177	221	0	0	0	0	0	0	0	0	0
13	Sale and Leaseback Transaction +	3	0	0	0	0	0	0	0	0	0	0	0	0	0
14	Gain (Loss) on Disposition of Business +	272	205	86	9	0	0	0	0	0	0	0	0	0	0
15	Total Operating Expenses +	0	-33,541	-21,368	-18,990	-18,519	-17,074	-16,568	-15,746	-15,278	-14,231	-14,082	-13,933	-12,244	-11,314
16	Total Operating Income (Loss) +	13,911	11,987	4,021	9,538	10,338	9,454	8,799	8,037	7,210	6,331	6,137	6,425	6,046	4,794
17	Investment Income +	0	0	0	21	20	21	15	8	4	4	3	5	21	0
18	Total Investment Income +	781	854	660	0	0	0	0	0	0	0	0	0	0	0
19	Investment Income +	-35	-42	-3	0	0	0	0	0	0	0	0	0	0	0
20	Total Investment Income +	798	1,011	660	0	0	0	0	0	0	0	0	0	0	0
21	Other Nonoperating Expense +	0	0	0	-208	-28	-21	0	0	0	0	0	0	0	0
22	Total Other Nonoperating Income (Expense) +	206	124	4	-208	-28	0	0	0	0	0	0	0	0	0
23	Finance Lease +	58	44	0	0	0	0	0	0	0	0	0	0	0	0
24	Total Interest Expense +	2,907	3,035	2,619	1,062	1,078	859	615	517	561	588	539	530	530	0
25	Gain (Loss) on Extinguishment of Debt +	-619	0	0	0	0	0	0	0	0	0	0	0	0	0
26	Write off of Deferred Debt Issuance Cost +	-664	0	0	0	0	0	0	0	0	0	0	0	0	0
27	Total Gain (Loss) on Extinguishment of Debt +	1,440	79	0	0	643	0	521	0	348	0	0	0	0	0
28	Total Income (Loss) from Continuing Operations before Equity Method Investments +	9,770	8,997	1,406	8,268	8,637	8,616	7,678	7,528	6,305	5,747	5,601	5,900	5,537	4,359
29	Total Income (Loss) from Continuing Operations before Income Taxes +	0	0	1,406	8,268	8,637	0	0	0	0	0	0	0	0	0
30	Income Tax Expense (Benefit) +	-2,569	-2,366	-2,002	-1,637	-3,317	-3,386	-3,033	-2,928	-2,436	-2,258	-2,179	-2,200	-2,193	-1,722
31	Total Income (Loss) from Continuing Operations +	4,632	4,265	-2,598	4,994	2,003	1,844	1,612	1,672	1,433	1,231	1,243	1,500	1,151	0
32	Discontinued Operation +	0	0	0	-13	-2	15	-1	-12	0	0	0	0	0	0
33	Discontinued Operation +	269	-205	-86	0	0	0	0	0	0	0	0	0	0	0
34	Discontinued Operation +	-12	0	0	-13	-2	0	0	0	0	0	24	19	214	0
35	Discontinued Operation +	-15	0	0	-8	-1	-6	0	4	5	-95	22	21	132	0
36	Total Income (Loss) from Discontinued Operations +	-9	0	0	-8	-1	9	-1	-8	-7	-31	2	-4	-132	0
37	Total Net Income (Loss) +	7,192	6,631	-596	6,623	5,319	5,239	4,644	4,592	3,862	3,458	3,424	3,696	3,212	0
38	Total Net Income (Loss) Attributable to Redeemable Noncontrolling Interest +	0	0	0	0	1	1	0	0	0	0	0	0	0	0
39	Total Net Income (Loss) Attributable to Noncontrolling Interest +	-13	3	2	-1	-2	-2	0	0	2	4	3	0	0	0
40	Total Net Income (Loss) Attributable to Parent +	7,179	6,634	-594	6,622	5,317	5,237	4,644	0	0	0	3,427	3,696	3,212	2,637
41	Total Net Income (Loss) Available to Common Stockholders +	0	0	0	0	0	5,237	4,644	4,592	3,864	3,462	3,427	3,696	3,198	2,623
42	Income (Loss) from Continuing Operations +	7,201	6,631	-596	6,631	5,320	5,230	4,645	4,600	3,869	3,489	3,422	3,700	3,344	0
43	Total Income (Loss) from Continuing Operations +	14,389	13,260	-1,193	13,237	10,611	10,432	9,271	9,200	7,740	6,982	6,847	7,400	6,688	2,637
44	Income (Loss) from Discontinued Operations +	-9	0	0	-8	-1	9	-1	-8	-7	-31	2	-4	-132	0
45	Income (Loss) from Continuing Operations +	5.49	5.10	-0.57	6.48	4.93	4.65	3.98	3.78	3.05	2.61	2.51	2.58	2.32	1.97
46	Discontinued Operation +	-0.01	0	0	-0.01	0	0	0	0	0	0	0	0	0	0
47	Total Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations +	0	0	0	-0.02	0	0.01	0	-0.01	-0.01	-0.02	-0.01	-0.01	-0.09	0
48	Total Earnings Per Share +	5.48	5.10	-0.57	6.47	4.93	4.66	3.98	3.77	3.04	2.59	2.51	2.58	2.23	1.97
49	Income (Loss) from Continuing Operations +	5.49	5.10	-0.57	6.48	4.93	4.65	3.98	3.78	3.05	2.61	2.51	2.58	2.32	1.97
50	Income (Loss) from Continuing Operations +	5.47	5.08	-0.57	6.45	4.91	4.62	3.96	3.75	3.02	2.59	2.49	2.55	2.27	1.92
51	Discontinued Operation +	-0.01	0	0	-0.01	0	0	0	0	0	0	0	0	0	0
52	Total Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations +	0	0	0	-0.02	0	0.01	0	-0.01	-0.01	-0.02	-0.01	-0.01	-0.09	0
53	Total Earnings Per Share +	5.46	5.08	-0.57	6.44	4.90	4.63	3.96	3.74	3.02	2.57	2.49	2.55	2.18	1.92
54	Common Stock Dividends +	2	2	2	2	1.70	1.40	1.10	0.90	0.65	0.50	0.35	0.30	0.26	0.23
55	Common Stock Dividends +	0	0	4	4	0	0	0	0	0	0	0	0	0	0
56	Discontinued Operation +	-12	0	0	-13	-2	0	0	0	0	0	24	19	214	0

Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.